GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Antibiotic Properties of Artificial Agonists for a Bacterial Riboswitch

$435,776
Juliane K Strauss-Soukup · Creighton University · R15 · FY2010 · GM

Ribosome Structure and Function

$435,775
Harry F Noller · University Of California Santa Cruz · R01 · FY2011 · GM

Modulation of Host Responses by Mycobacterium Tuberculosis

$435,600
Jyothi Rengarajan · Emory University · R01 · FY2012 · AI

Modulation of Host Responses by Mycobacterium Tuberculosis

$435,600
Jyothi Rengarajan · Emory University · R01 · FY2014 · AI

Modulation of Host Responses by Mycobacterium Tuberculosis

$435,600
Jyothi Rengarajan · Emory University · R01 · FY2011 · AI

Discovery of Gene Variants and Mechanisms Underlying Salt-Sensitive Hypertension

$435,540
Laura A Cox · Texas Biomedical Research Institute · R01 · FY2013 · HL

The role of neutrophils in the age-driven decline in anti-pneumococcal vaccine responses

$435,435
Elsa Bou Ghanem · State University Of New York At Buffalo · R01 · FY2025 · AG

Active Vaccination and Passive Antibody Strategies to Prevent Klebsiella and Pseudomonas Disease

$435,352
Raphael Simon · University Of Maryland Baltimore · U19 · FY2019 · AI

Biomaterials that Prevent Biofilm Colonization and Device-based Infections

$435,146
James D. Bryers · University Of Washington · R01 · FY2012 · EB

Subproject 4: Role of Pumps in Resistance, Physiology, and Infection

$435,126
David C Hooper · Massachusetts Eye And Ear Infirmary · P01 · FY2022 · AI

Plasmid-mediated Quinolone Resistance

$435,000
David C Hooper · Massachusetts General Hospital · R01 · FY2017 · AI

Plasmid-mediated Quinolone Resistance

$435,000
David C Hooper · Massachusetts General Hospital · R01 · FY2015 · AI

Plasmid-mediated Quinolone Resistance

$435,000
David C Hooper · Massachusetts General Hospital · R01 · FY2018 · AI

Plasmid-mediated Quinolone Resistance

$435,000
David C Hooper · Massachusetts General Hospital · R01 · FY2016 · AI

Mechanistic aspects of the final step of heme b biosynthesis in Gram-positive bacteria

$435,000
Gudrun Susanne Lukat-Rodgers · North Dakota State University · R15 · FY2019 · GM

Dynamics of the Activity of Antimicrobial Peptides at the Population and the Single-Cell Levels

$435,000
Sattar Taheri Araghi · California State University Northridge · R15 · FY2017 · GM

A novel multifunctional role of diverse substrate binding and import by the Haemophilus Sap transporter

$434,997
Kevin M Mason · Research Inst Nationwide Children'S Hosp · R01 · FY2019 · AI

A novel multifunctional role of diverse substrate binding and import by the Haemophilus Sap transporter

$434,861
Kevin M Mason · Research Inst Nationwide Children'S Hosp · R01 · FY2020 · AI

Role of Toxins in Endophthalmitis

$434,676
Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R01 · FY2010 · EY

Implementing Diagnostic Stewardship to Reduce Antibiotic Use and Resistance in Critically Ill Children

$434,458
Aaron M Milstone · Johns Hopkins University · R18 · FY2020 · HS

Discovery of Disulfiram as an Anti-MRSA Antibiotic Adjuvant

$434,180
Timothy Edward Long · Marshall University · R15 · FY2020 · AI

MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN

$434,135
Marco Colonna · Washington University · R01 · FY2021 · DK

In Vitro Screening Core

$433,872
Nancy Day Connell · Rbhs-New Jersey Medical School · U19 · FY2016 · AI

Parallel phenotyping to dissect genetic determinants of bacterial strain diversity

$433,736
Allison Carey · University Of Utah · DP2 · FY2022 · AI

Quinolone and multidrug resistance in Staphylococcus aureus

$433,694
David C Hooper · Massachusetts General Hospital · R37 · FY2012 · AI